INTRODUCTION
Spirometry is a useful tool to help the practitioner distinguish normal from abnormal pulmonary function, delineate obstructive from restrictive defects, and monitor the disease or treatment. Most hospitals and many specialty offices (eg, pulmonology and allergy) have ready access to and familiarity with spirometry. The pediatric primary care practice may not have a spirometer or may lack experienced personnel to properly administer and/or interpret the test results. A published survey with data from 360 primary care practices revealed that only 52% used spirometry for patients with a diagnosis of asthma, and of those, only 35% of pediatric practices (vs 75% of family medicine practices) used spirometry in clinical practice. (1) Equipment for spirometry is readily available at a reasonable cost, and the procedure and interpretation of results are billable services that can be used by any primary care practice. The interpretation of results can be performed by the primary care physician, possibly with the help of a specialist.
Who?
Most children older than 5 years, who can cooperatively take deep breaths, can be coached to perform a good spirometry test. Younger children or those with developmental delays, certain disabling conditions, or poor behavior may not be willing or able to perform the test. (For those too young to voluntarily exhale into AUTHOR DISCLOSURE Dr Sadof has disclosed no financial relationships relevant to this article. Dr Kaslovsky has disclosed he is a speaker for Teva Pharmaceutical Industries Ltd. This commentary does not contain a discussion of an unapproved/investigative use of a commercial product/device. What?
ABBREVIATIONS
Spirometers can be of 2 general types: volume displacement or flow measurement. Those that measure volume have a (usually 10-L) drum with a piston, such that the change in volume over time is measured directly, and flow rates are calculated (change of volume over time). These devices are computer linked and usually not easily portable, tend to be more costly, and most likely would not be useful to a primary care practice. Flow-sensing devices can be handheld and are easily portable from room to room in the office. They use disposable sensors, referred to as pneumotachometers, which sense the flow over time. This measurement of flow is used to calculate the volumes. These devices may be selfcontained or connected to a laptop or desktop computer. Any spirometer used in an office setting should meet the American Thoracic Society/European Respiratory Society recommendations for spirometry (available online at http:// www.thoracic.org/statements/resources/pft/pft2.pdf). (4)(5) The first chapter of this document is essential reading for all clinical staff, with descriptions of standards for hygiene, calibration, quality control, and other maintenance issues. (5) Measurements made by the spirometer are as follows: • Forced vital capacity (FVC): the total volume of air exhaled after maximal inhalation.
• Forced expiratory volume in 1 second (FEV 1 ): the volume of air exhaled in the first second. Reversibility after inhaled bronchodilator is determined by an increase in FEV 1 of 12% or more or 200 mL from baseline.
• Ratio of FEV 1 to FVC.
• Peak expiratory flow rate: the highest flow obtained during the forced expiratory maneuver, expressed as liters per second. This is different than the peak flow meter readings, which are expressed in liters per minute.
• Forced expiratory volume between 25% and 75% of vital capacity (FEF 25%-75% ): the flow in the midportion of the forced expiratory maneuver, which is a reflection of the flow from the smaller airways.
• Forced expiratory time: the time that the patient sustains the expiratory maneuver.
Why?
There are many reasons to perform spirometry in a pediatric patient:
• To establish whether pulmonary mechanics are normal in a child with symptoms.
• To define the nature and severity of any pulmonary dysfunction (obstructive vs restrictive defect).
• To define the site of airway obstruction-central vs peripheral or intrathoracic vs extrathoracic.
• To follow the course of pulmonary disease or assess the effect of therapy.
• To establish the presence or absence of airway reactivity.
• To assess the risks of diagnostic or therapeutic procedures.
• To monitor for adverse effects of chemotherapy or radiation therapy.
• To predict prognosis or assess disability and to assess the effect of disease on lung growth. You can do this in your office! It is important to identify what barriers exist in your office to map out a plan for sustainable change. Time, patient flow, and quality are often cited as barriers to spirometry implementation. It is important to remember that each practice is different. Some practices will group asthma visits that include spirometry (each practitioner has several dedicated asthma sessions a month); others will prereview patients before each session to develop a better patient flow strategy to allow for spirometry. An individualized implementation that matches existing practice culture appears to be the best strategy to successfully change and sustain practice patterns. (6) Although regional (7) and distance or Internet-based training efforts (8) have been successful at improving the spirometry capacity and guideline-based asthma care in primary care pediatricians' offices, many busy practitioners still struggle with implementing and sustaining routine spirometry into their busy practice.
The planned asthma visit (Table 1) is a tool that can be used to implement spirometry in the busy practice. (9) In this model, patients with asthma can be proactively assessed for control with an asthma control test and spirometry. This is a time when trained office staff can help to identify asthma triggers in the home, school, and work environment. Medications and administration technique can be reviewed with the patient and family, and immunizations, such as influenza, can be given. Spirometry can also be performed with a bronchodilator for initial visits to help establish reversibility. Spirometry without a bronchodilator can be performed at follow-up visits to monitor control. All this can be completed before the practitioner enters the room. The practitioner will review all the results, examine the patient, and create or update a written action plan. Follow-up can be based on severity, asthma control, and seasonal pattern. We recommend follow-up visits in 2 to 6 weeks for asthma that is not well controlled and 3 to 6 months for asthma that is well controlled. Key points for assessing asthma control and severity and stepwise therapy have been condensed to a very usable format at the National Center for Medical Home implementation website (10) and are displayed in Appendix A (information adapted from Texas Children's Health Plan's Key Points for Asthma Guideline Implementation).
Once the pediatrician's office staff gains comfort in spirometry, it can become a useful tool in a busy practice. The information generated by spirometry will inform the patient and the practitioner when to step up and when to step down therapy.
Consider the asthma patient who is a poor perceiver of symptoms. This type of patient tends to report regular controller medication use, with good technique, rarely reports needing albuterol, and rarely notices dyspnea on exertion. When sick, this patient becomes very ill very quickly and may require intensive care. Often this patient has been to the specialist and does not feel the need for further visits because their asthma is "just fine." Spirometry results obtained in the primary care office can reveal unnoticed obstruction and provide immediate feedback to the physician, patient, and family.
COMMON PITFALLS
Calibration is a common pitfall. Because atmospheric pressure and temperature are continuously changing, volumedisplacement spirometers may have to be calibrated daily. This requires a fixed-volume (usually 3-L) syringe with which to pump air into and out of the spirometer. The device then recognizes this exact volume as 3 L and is then ready to use for the day. For flow-based spirometers, the disposable pneumotachometer is factory calibrated and coded so that the software adjusts for each calibrated unit.
Another common pitfall is test performance. Office personnel who perform the spirometry have to be patient, nonthreatening, and able to get the best effort out of each patient they test. Merely purchasing a spirometer and assigning an untrained person to administer the test will not produce adequate results. The American Thoracic Society criteria for acceptable spirometry call for a 3-second exhalation in children (6 seconds for adults and older children), with a zero flow plateau at the end of the breath, and an appropriately rapid start of exhalation (back-extrapolated volume <5%). Cough, premature termination of exhalation, and lack of reproducibility between efforts may render the test result uninterpretable. (11)(12) There may be useful information gathered from less than optimal studies. At least 3 trials should be performed, in which the highest FEV 1 and FVC values should not differ by more than 5%. (11)(12)
PREDICTED NORMAL VALUES
Reference values for spirometry are derived from studies of specific populations of healthy people. One example is that of National Health and Nutrition Examination Survey III. (13) Popular pediatric predicted sets are those of Hsu et al, (14) Polgar and Promadhat, (15) and Wang et al. (16) The age of the patient should be represented in the reference set used. Other factors that are important are sex, height, weight, and race/ethnicity. Because height plays a big role in determining the predicted values, an accurate height measurement should be performed at the time of spirometry. For nonambulatory patients, arm span can be used to estimate height. (17)(18) Commercial spirometers usually will include a choice of reference values, such that the user can choose one to match the specific patient population being tested.
NORMAL SPIROMETRY
In general, parameters above 80% of predicted (and an FEV 1 /FVC ratio >80%) are considered normal results ( Figure 1) . (19) FLOW-VOLUME LOOPS A plot of flow vs volume is generated during spirometry and should be examined to determine the acceptability of the test and to give a preliminary idea of the interpretative pattern. A normal flow-volume loop will show the vital capacity on the • Spirometry is performed with bronchodilator at the initial visit to establish diagnosis (or without bronchodilator for follow-up)
• Practitioner reviews results
• Asthma action plan is reviewed or created
• Follow-up appointment 1-6 months based on severity and/or control 
COACHING THE PATIENT
To improve reliability, the patient should take a few tidal breaths, inhale deeply and completely, and then blow rapidly and as long as possible, until there is zero flow, before inhaling the next breath. Computer-operated systems often have child-friendly incentives, such as a rocket ship, blowing out candles on a cake, and other animations that encourage continued exhalation efforts. The person doing the coaching has to be child-friendly and patient, yet has to have the technical expertise to operate the equipment while coaching the child. It is essential that the child have a tight seal on the mouthpiece, with the tongue under and not in the mouthpiece. Nose clips are used to prevent loss of air through the nose. The instructions should be "take in a deep breath and blow, blow, blow." until the test is completed. Three reproducible trials are recommended, and up to 8 can be performed and stored on most software. The 2 largest FVC results should be within 150 mL of each other (within 100 mL for FVC <1 L). In some children, only 1 or 2 acceptable tests may be performed. For younger children, a parent may be needed during the test, but older patients should be able to perform the testing without parental input.
The flow-volume loop must be examined to ensure the validity of the test. It should rapidly rise to a sharp peak, have a smooth expiratory curve, and not terminate until full exhalation has been achieved. Cough, sudden termination of exhalation, and uneven expiratory effort are common errors seen in flow-volume loops. The Centers for Disease Control and Prevention has a web-based poster that illustrates normal flow-volume loops and those with common errors. 
OBSTRUCTIVE LUNG DISEASE
Obstructive lung disease is characterized by decreased airflow, as measured by FEV 1 and FEF 25%-75% . The FVC is usually normal in mild disease, but with more severe disease, air trapping causes the vital capacity to decrease as the residual volume increases. It is possible for both FVC and FEV 1 to be normal, but if the ratio of FEV 1 /FVC ratio is less than 80%, obstructive lung disease is present. (19) When the FEV 1 and FEF 25%-75% are diminished, the flow-volume loop will have a scooped out appearance because of lower flow Figure 1 . Two examples of normal spirometry results. The upper has a short exhalation time (horizontal arrows) such as would be seen in a younger child. The lower has exhalation time longer than 6 seconds, such as would be expected in an older child or adult. FEF 25%-75 indicates expiratory volume between 25% and 75% of vital capacity; FEF 50% indicates forced expiratory flow at 50%; FET, forced expiratory time; FEV 1 , forced expiratory volume in 1 second; FIF 50% , forced inspiratory flow at 50%; FVC, forced vital capacity; and PEFR, peak expiratory flow rate. rates (Figures 3 and 4) . Obstructive lung conditions other than asthma include chronic obstructive pulmonary disease, bronchiolitis, bronchiectasis, cystic fibrosis, congestive heart failure, sarcoidosis, or pulmonary embolism.
BRONCHODILATOR RESPONSE
In general, an increase in FEV 1 of greater than 12% (for low lung volumes, minimum change of 200 mL) and/or an increase in FEF 25%-75% of greater than 20% is considered a significant positive response to a bronchodilator ( Figure 3) . (19) 
RESTRICTIVE LUNG DISEASE
The defining characteristic of restrictive lung disease is decreased lung volume. The FVC decreases, whereas the measures of airflow, FEV 1 , and FEF 25%-75% are preserved. The key to recognition may lie in the ratio of FEV 1 /FVC, which increases as the denominator (the FVC) decreases. In addition, severe restriction will make all parameters decrease, except the FEV 1 /FVC ratio. The flow-volume loop retains its normal shape but becomes smaller as the vital capacity diminishes (Figures 5 and 6 ). Examples of restrictive lung diseases include muscular dystrophy, scoliosis, pulmonary fibrosis, and other types of pneumoconiosis.
VOCAL CORD DYSFUNCTION SYNDROME
Vocal cord dysfunction is a condition in which a patient attempts to inhale against partially or totally closed vocal cords, resulting in inspiratory obstruction. This results in flattening of the lower (inspiratory) limb of the flow-volume loop ( Figure 7 ). Vocal cord dysfunction is often misdiagnosed as asthma, with which it is often comorbid. (22) It occurs as the result of paradoxical closure of the vocal cords on inspiration, which produces stridor, dyspnea, and noises that are often misinterpreted as wheezing.
COMPARISON OF TEST RESULTS
The usual convention for defining significant change between test results is to have measured volumes (FVC and FEV 1 ) change by more than 10% and FEF 25%-75% by 20% to 30% (Figure 8 ). (19) 
EVIDENCE-BASED SUMMARY
On the basis of some research and consensus,_the 2007 NHLBI expert panel asthma guidelines recommend Figure 3 . Obstructive lung disease, as indicated by low forced expiratory volume in 1 second (FEV 1 )/forced vital capacity (FVC) ratio, despite normal values for the FVC and FEV 1 , and low forced expiratory flow between 25% and 75% of vital capacity (FEF 25%-75% ). The improvement in FEV 1 and FEF 25%-75% after bronchodilator is significant. FEF 50% indicates forced expiratory flow at 50%; FET, forced expiratory time; FIF 50% , forced inspiratory flow at 50%; and PEFR, peak expiratory flow rate. Restrictive lung disease is present. The forced vital capacity (FVC) and forced expiratory volume in 1 second (FEV 1 ) are low, but the FEV 1 /FVC ratio is relatively preserved (box), which is the key to recognition for restrictive patterns. FEF 25%-75% indicates expiratory flow between 25% and 75% of vital capacity; FEF 50% , forced expiratory flow at 50%; FET, forced expiratory time; FIF 50% , forced inspiratory flow at 50%; and PEFR, peak expiratory flow rate. spirometry be part of routine asthma diagnosis and monitoring of therapy. (3) Just as hypertension is managed by measuring blood pressure regularly and diabetes is managed by checking blood glucose levels, so should lung diseases should be managed by performing spirometry in capable patients. Multiple research studies have provided evidence indicating that with currently available equipment and proper training, primary care offices can and should be able to offer spirometry to test patients with pulmonary symptoms. (7)(8) Figure 6 . Flow-volume curve in restrictive lung disease. The shape is normal (ie, not scooped out), but the size of the curve is very small, indicating decreased volume, which is the key to recognition for restrictive flow-volume loops. FET indicates forced expiratory time; FEV 1 , forced expiratory volume in 1 second; FEV 3 , forced expiratory volume in 3 seconds; and FVC, forced vital capacity. 
